Evaluation of the knee pain alleviating effect on the long-term intake of hyaluronic acid containing diet (Hyabest J)

Evaluation of the knee pain alleviating effect on the long-term intake of hyaluronic acid containing diet (Hyabest J) - Hyabest J trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT1090220082

Enrollment

Registered

2012-03-12

Start date

2009-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

osteoarthritis

Interventions

Intervention type: Name of intervention:Hyabest J Dose form / Japanese Medical Device Nomenclature:CAPSULE Route of administration / Site of application:ORAL Dose per administration:200 mg Dosing freq

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Osteoarthritis, K/L grade 2 or 3

Exclusion criteria

Exclusion criteria: rheumatoid arthritis, inflammatory joint disease, secondary osteoarthritis. The subjects has significant problem with liver, kidney, moter nerve systems.

Design outcomes

Primary

Measure	Time frame
The Symptom of osteoarthritis	—

Countries

Japan

Contacts

Public ContactRyosuke Maysuoka

Kewpie Corporation

ryosuke_matsuoka@kewpie.co.jp+81-42-361-0026

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026